CellWell record HH-285411
Plasma gamma-glutamylglycine predicts the seroconversion of hepatitis B e antigen in patients with chronic hepatitis B
Ze-Hua Zhao; Zheng-Dong Qu; Xin-Hua Guo; Xue-Qi Yang; Qi An; Fang-Ming Zhou; Jinghui Tian; Yu-Chen Fan
Frontiers in Immunology ยท 2026
In plain language
In patients with chronic hepatitis B, plasma gamma-glutamylglycine was higher in HBeAg-positive patients, was negatively associated with HBeAg seroconversion, and contributed to HBeAg production in HBV-replicating cells.
- Evidence
- Emerging
- Design
- Primary research (design unspecified)
Cite this record: https://thecellwell.org/studies/HH-285411
Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.